Glycogen Storage Diseases and Inborn Errors of Galactose and Fructose Metabolism Flashcards

(33 cards)

1
Q

GSD I symptoms

A

*deficiency in glucose-6-phosphatase

  • hepatomegaly, but normal liver function –> protruding abdomen
  • “doll face”
  • truncal obesity
  • profound hypoglycemia after meal (contrary to FAO disorders)
  • hyperlactacidemia
  • hyperuricemia
  • hyperlipidemia, primarily hypertriglyceridemia (suggests increased cardiovascular risk)
  • increased bleeding time, perhaps due to decreased platelet aggregation
  • growth retardation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GSD 1b symptoms

A

1/5 of patients with GSD1; have all symptoms of GSD 1 plus:

  • neutropenia (low white blood cell count); neutrophil dysfuntion (impaired motility and migration)
  • risk of frequent and severe infections that can affect upper and lower respiratory tract, the skin, the urinary tract
  • protracted diarrhea, inflammatory bowel disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GSD I Complications

A
  • short stature
  • gout
  • osteoporosis
  • nephropathy
  • pulmonary hypertension
  • liver adenomas with risk of malignant transformation
  • polycystic ovaries
  • necrotizing pancreatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of GSD I

  • fasting profile
  • enzyme assay
  • molecular (genetics)
A

Characteristic fasting profile
Measure G6Pase activity + glycogen concentration in liver tissue

Enzyme assay

  • measure released free phosphate
  • measure protein concentration of liver homogenate

Molecular

  • normal cell count–> G6PC = GSD 1A.
  • neutropenia –> G6PT1 = GSD 1b
  • if both genes show no mutation, back to start of specific assays in liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GSD I conventional treatment

A

MAIN GOAL: do not let patient become hypoglycemic

  • frequent feedings (avoid fasting mode)
  • restruct complex carbs
  • cornstarch supplement
  • night-time nasogastric tube feedings
  • nutrient supplementation
  • ALLOPURINOL for hyperuricemia
  • bicarbonate or citrate
  • G-CSF for neutropenia
  • ACE inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GSD I and liver transplantation

A

GSD Ia patients may have liver adenoma

  • corrects metabolic abnormalities
  • neutropenia persists in GSD I non-a
  • reserved for patients with liver adenoma (+malignant growth)…but no good early markers
  • not standard of care because there are effective dietary therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Short fasting in GSD I

A

glucose is decreasing more rapidly than in controls, lactate increases. In controls, lactate does not increase
Excess lactate –> metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GSD III (Cori, Forbes) etiology

A

deficiency of glycogen debranching enzyme

GSD IIIa –> liver and muscle
GSD IIIb –> only liver

as opposed to GSD I, no fasting lactic acidemia, but they do have slight postprandial hyperlactatemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GSD III (Cori, Forbes)

  • symptoms
  • findings
A

SYMPTOMS

  • hepatomegaly
  • protruding abdomen
  • normal kidneys
  • growth delay
  • muscle weakness

FINDINGS

  • hypoglycemia
  • hyperlipidemia
  • elevated creatine kinase (CK)
  • peripheral neuropathy
  • cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Minimal fasting in GSD III

A

rapid, progressive hypoglycemia
rapid elevation of ketone bodies
no acidosis –> lactate plus ketones is low enough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnosis of GSD III

A

suspected in infancy

  • metabolic profile: look for ketotic hypoglycemia, normal lactate at short fast
  • elevated CK

measure debranching enzyme in leukocytes, RBCs, fibroblasts

DNA investigation

  • IIIb - exon 3
  • IIIa - beyond exon 3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GSD III

  • treatment
  • complications
A

TREATMENT

  • high protein diet (carbs will accumulate)
  • frequent feedings if hypoglycemia
  • supplement 3-OH butyrate

COMPLICATIONS

  • liver cirrhosis
  • liver cancer
  • muscle hypotonia and wasting developing with age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GSD VI (Hers)

  • deficient in what enzyme?
  • genetics
A

Liver phosphorylase deficiency

Gene defect PYGL on chromosome 14, autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GSD VI (Hers) symptoms

A

isolated hepatomegaly
growth/motor development delay
mild fasting hypoglycemia and fasting ketosis
hyperlipidemia and elevated LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GSD VI (Hers)

  • diagnosis
  • treatment
  • prognosis
A

DIAGNOSIS

  • enzyme assay: liver biopsy
  • molecular diagnosis (PYGL) most common

TREATMENT
- avoid prolonged fasting and alcohol

PROGNOSIS: most symptoms resolve at puberty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GSD IXa etiology

A

X-linked; affects only males
liver phosphorylase B-kinase deficiency

PHKA2 on chr X

similar to, more common than GSD VI

17
Q

GSD IXa symptoms

A

isolated hepatomegaly
growth/motor development delay
mild fasting hypoglycemia + ketosis
hyperlipidemia and elevated LFTs

muscle involvement

18
Q

GSD IXa

  • diagnosis
  • treatment
  • prognosis
A

DIAGNOSIS
- enzyme assay in RBC, might need tissue for isoenzymes

TREATMENT
- dietary; bedtime snack

PROGNOSIS
- Benign, most symptoms resolve during puberty (ie hepatomegaly and failure to grow resolves)

19
Q

GSD 0

  • deficiency of what?
  • genetics
A

deficiency of either:

  • liver glycogen synthase (GYS2)
  • muscle glycogen synthase (GYS1) (expressed in muscle AND liver)

GYS1 and 2: 70% homologous, located on diff chromosomes

frequently not diagnosed because it mimics functional ketotic hypoglycemia

20
Q

GSD 0 symptoms

A

fasting-induced ketotic hypoglycemia with normal lactate
drowsiness, fatigue
convulsions
no hepatomegaly
often: postprandial hyperglycemia and hyperlactacidemia with glycosuria

21
Q

GSD 0

  • diagnosis
  • treatment
  • prognosis
A

DIAGNOSIS

  • molecular genetic analysis of GYS2
  • Enzyme assay requires liver biopsy

TREATMENT
- dietary

PROGNOSIS: good, but females at risk of hypoglycemia during pregnancy

22
Q

GSD V (McArdle)

  • deficiency in what?
  • genetics
A

myophosphorylase deficiency

PYGM gene on chromosome 12q13

23
Q

GSD V (McArdle) symptoms

A

child-onset exercise intolerance

brief exertion may cause muscle cramps, myoglobinuria, hyperuricemia, mild CPK elevation

24
Q

GSD V (McArdle)

  • diagnosis
  • treatment
  • prognosis
A

DIAGNOSIS

  • bicycle/treadmill test to detect increased uric acid and ammonia
  • if treadmill test is abnormal, enzyme assay

TREATMENT

  • avoid strenuous exercise
  • protein-rich diet, glucose, fructose

good prognosis

25
GSD VII (Tarui) etiology
muscle phosphofructokinase deficiency PFKM gene on chrom 11 prevalent in Japanese and Ashkenazim
26
GSD VII (Tarui) symptoms
child-onset exercise intolerance brief exertion may cause muscle cramps, myoglobinuria, hyperuricemia, mild CPK elevation compensated hemolysis
27
GSD VII (Tarui) - diagnosis - treatment - prognosis
DIAGNOSIS - bicycle/treadmill test to detect increased uric acid and ammonia - if treadmill test is abnormal, enzyme assay TREATMENT - avoid strenuous exercise PROGNOSIS: good
28
AMPK deficiency: gene and inheritance
PRKAG2 on chr 7 | AD, full penetrance
29
AMPK deficiency: symptoms
onset typically late adolescence | cardiac symptoms including hypertrophy, familial hypertrophic cardiomyopathy with WPW syndrome
30
AMPK deficiency: - diagnosis - treatment - differential diagnoses
DIAGNOSIS: - ECG - heart biopsy - molecular genetics TREATMENT - pacemaker/defibrillator - heart transplant DDx: Pompe, Danon, Fabry
31
Lafora Disease etiology
mutations in Laforin-malin complex, which brings glycogen synthase from neurons to proteosome for glycogen breakdown - accumulation of branched chain glycogen - triggers neuronal apoptosis EPM2A encodes laforin EPM2B encodes malin
32
Lafora Disease symptoms
adolescent onset of myoclonic epilepsy and absence seizures progressing to dementia with visual loss, apraxia, and aphasia ultimately leads to vegetative state
33
Lafora disease: - diagnosis - treatment - prognosis
DIAGNOSIS - skin biopsy to detect Lafora bodies - mutation analysis to confirm TREATMENT: none Poor prognosis, death within decade of disease onset